Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles (Q39384668)

11 September 2017

Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles (English)

1 reference

11 September 2017

0 references

Nirupama Sabnis

1

1 reference

11 September 2017

Maya Nair

2

1 reference

11 September 2017

Mervyn Israel

3

1 reference

11 September 2017

Walter J McConathy

4

1 reference

11 September 2017

Andras G Lacko

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

22 February 2012

1 reference

International Journal of Nanomedicine

11 September 2017

1 reference

11 September 2017

7

1 reference

11 September 2017

975-983

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

11 September 2017

start time

1 February 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

A novel Doxorubicin prodrug with controllable photolysis activation for cancer chemotherapy

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Nanoparticle therapeutics: an emerging treatment modality for cancer

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Applications of nanobiotechnology in clinical diagnostics

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Nanotechnological applications in medicine

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by electron microscopy

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Establishment and characterization of a human prostatic carcinoma cell line (PC-3)

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Valrubicin in a topical formulation treats psoriasis in a xenograft transplantation model

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Evaluation of gemfibrozil therapy: predictive response from lipoprotein subfraction analysis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Current recommendations for the management of bladder cancer. Drug therapy

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Cardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injury

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Topical application of valrubicin has a beneficial effect on developing skin tumors

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Optimized bacterial expression of human apolipoprotein A-I.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Nanostructured lipid matrices for improved microencapsulation of drugs.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

High density lipoprotein complexes as delivery vehicles for anticancer drugs

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3289451

Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder

21 August 2018

1 reference

12 December 2020

Development of 5-iodo-2'-deoxyuridine milling process to reduce initial burst release from PLGA microparticles

1 reference

12 December 2020

Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerate

1 reference

12 December 2020

Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase

1 reference

12 December 2020

Dynamic dialysis for the drug release evaluation from doxorubicin–gelatin nanoparticle conjugates

1 reference

12 December 2020

Intracellular drug delivery by genetically engineered high-density lipoprotein nanoparticles

1 reference

12 December 2020

Validation of the reconstituted high-density lipoprotein (rHDL) drug delivery platform using dilauryl fluorescein (DLF)

1 reference

12 December 2020

Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerate

1 reference

12 December 2020

Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat

1 reference

12 December 2020

Identifiers

DOI

10.2147/IJN.S28029

1 reference

release_cvge7fgukjfzjornijd2uycuva

11 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cvge7fgukjfzjornijd2uycuva

24 November 2022

mapped directly with Wikidata item

1 reference

11 September 2017

PubMed publication ID

22393294

1 reference